225 related articles for article (PubMed ID: 28754475)
1. Detection of enterotoxin and protease genes among Hungarian clinical Bacteroides fragilis isolates.
Sárvári KP; Sóki J; Iván M; Miszti C; Latkóczy K; Melegh SZ; Urbán E
Anaerobe; 2017 Dec; 48():98-102. PubMed ID: 28754475
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait.
Jamal W; Khodakhast FB; AlAzmi A; Sόki J; AlHashem G; Rotimi VO
BMC Microbiol; 2020 Jan; 20(1):14. PubMed ID: 31941446
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and analysis of rare cfiA-bft doubly positive Bacteroides fragilis strains.
Sóki J; Eitel Z; Terhes G; Nagy E; Urbán E;
Anaerobe; 2013 Oct; 23():70-3. PubMed ID: 23796697
[TBL] [Abstract][Full Text] [Related]
4. Activation Mechanism of the Bacteroides fragilis Cysteine Peptidase, Fragipain.
Herrou J; Choi VM; Bubeck Wardenburg J; Crosson S
Biochemistry; 2016 Jul; 55(29):4077-84. PubMed ID: 27379832
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of enterotoxin and antibiotic resistance genes in clinical and intestinal Bacteroides fragilis group isolates in Turkey.
Kangaba AA; Saglam FY; Tokman HB; Torun M; Torun MM
Anaerobe; 2015 Oct; 35(Pt B):72-6. PubMed ID: 26219215
[TBL] [Abstract][Full Text] [Related]
6. The association between fecal enterotoxigenic B. fragilis with colorectal cancer.
Haghi F; Goli E; Mirzaei B; Zeighami H
BMC Cancer; 2019 Sep; 19(1):879. PubMed ID: 31488085
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G
Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
[TBL] [Abstract][Full Text] [Related]
8. The presence of antibiotic resistance genes and bft genes as well as antibiotic susceptibility testing of Bacteroides fragilis strains isolated from inpatients of the Infant Jesus Teaching Hospital, Warsaw during 2007-2012.
Kierzkowska M; Majewska A; Szymanek-Majchrzak K; Sawicka-Grzelak A; Mlynarczyk A; Mlynarczyk G
Anaerobe; 2019 Apr; 56():109-115. PubMed ID: 30844502
[TBL] [Abstract][Full Text] [Related]
9. Bacteroides fragilis: A whole MALDI-based workflow from identification to confirmation of carbapenemase production for routine laboratories.
Cordovana M; Kostrzewa M; Sóki J; Witt E; Ambretti S; Pranada AB
Anaerobe; 2018 Dec; 54():246-253. PubMed ID: 29626622
[TBL] [Abstract][Full Text] [Related]
10. Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice.
Choi VM; Herrou J; Hecht AL; Teoh WP; Turner JR; Crosson S; Bubeck Wardenburg J
Nat Med; 2016 May; 22(5):563-7. PubMed ID: 27089515
[TBL] [Abstract][Full Text] [Related]
11. Determination of bft gene subtypes in Bacteroides fragilis clinical isolates.
Avila-Campos MJ; Liu C; Song Y; Rowlinson MC; Finegold SM
J Clin Microbiol; 2007 Apr; 45(4):1336-8. PubMed ID: 17301286
[TBL] [Abstract][Full Text] [Related]
12. The alleles of the bft gene are distributed differently among enterotoxigenic Bacteroides fragilis strains from human sources and can be present in double copies.
Scotto d'Abusco AS; Del Grosso M; Censini S; Covacci A; Pantosti A
J Clin Microbiol; 2000 Feb; 38(2):607-12. PubMed ID: 10655354
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Nagy E; Becker S; Sóki J; Urbán E; Kostrzewa M
J Med Microbiol; 2011 Nov; 60(Pt 11):1584-1590. PubMed ID: 21680764
[TBL] [Abstract][Full Text] [Related]
14. Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease.
Rashidan M; Azimirad M; Alebouyeh M; Ghobakhlou M; Asadzadeh Aghdaei H; Zali MR
Anaerobe; 2018 Apr; 50():93-100. PubMed ID: 29454108
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the pathogenicity of the Bacteroides fragilis toxin gene subtypes in gnotobiotic mice.
Nakano V; Gomes DA; Arantes RM; Nicoli JR; Avila-Campos MJ
Curr Microbiol; 2006 Aug; 53(2):113-7. PubMed ID: 16832728
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance, prevalence of resistance genes, and molecular characterization in intestinal Bacteroides fragilis group isolates.
Kouhsari E; Mohammadzadeh N; Kashanizadeh MG; Saghafi MM; Hallajzadeh M; Fattahi A; Ahmadi A; Niknejad F; Ghafouri Z; Asadi A; Boujary Nasrabadi MR
APMIS; 2019 Jun; 127(6):454-461. PubMed ID: 30803024
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antimicrobial resistance and the cfiA resistance gene in Danish Bacteroides fragilis group isolates since 1973.
Ferløv-Schwensen SA; Sydenham TV; Hansen KCM; Hoegh SV; Justesen US
Int J Antimicrob Agents; 2017 Oct; 50(4):552-556. PubMed ID: 28666749
[TBL] [Abstract][Full Text] [Related]
18. The distribution of the bft alleles among enterotoxigenic Bacteroides fragilis strains from stool specimens and extraintestinal sites.
Ulger Toprak N; Rajendram D; Yagci A; Gharbia S; Shah HN; Gulluoglu BM; Akin LM; Demirkalem P; Celenk T; Soyletir G
Anaerobe; 2006 Apr; 12(2):71-4. PubMed ID: 16701617
[TBL] [Abstract][Full Text] [Related]
19. Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes.
Gutacker M; Valsangiacomo C; Piffaretti JC
Microbiology (Reading); 2000 May; 146 ( Pt 5)():1241-1254. PubMed ID: 10832652
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS.
Jeverica S; Sóki J; Premru MM; Nagy E; Papst L
Anaerobe; 2019 Aug; 58():30-34. PubMed ID: 30716401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
